What ≥99% Peptide Purity Actually Means

"99% purity" appears on nearly every research peptide sold. It is a meaningful specification and it is routinely misunderstood, because it describes a narrower property than most purchasers assume.

What the number measures

Chromatographic purity by HPLC is a ratio of peak areas: the main peak divided by the sum of all detected peaks. A result of 99.2% means that among the UV-absorbing species the detector observed, the principal component accounted for 99.2% of the total absorbance.

Two constraints are embedded in that sentence:

• Among the species the detector observed. Anything that does not absorb at the detection wavelength is invisible. Inorganic salts and water are excluded from the calculation entirely.
• That the column resolved. An impurity co-eluting with the main peak is counted as product.

So 99% purity means: of the peptide-like material detected and resolved, 99% was the target. It does not mean the vial is 99% target compound by mass.

The mass question

A vial labeled 10 mg contains 10 mg of lyophilized solid. That solid is the peptide plus everything freeze-dried along with it:

• Bound salts. Peptides come off purification as salts, and that associated mass can be 5–20% of the total depending on how many basic residues the sequence carries.
• Bound water. Lyophilized peptides are hygroscopic. Residual and re-absorbed water typically accounts for 3–8%.
• Residual solvent. Trace acetonitrile and TFA from purification.

Net peptide content is the figure that accounts for all of this. It is determined by amino acid analysis or quantitative nitrogen determination and is typically 70–90% of gross mass.

A worked example

A 10 mg vial of a peptide at 99.3% HPLC purity with 82% net peptide content and a molecular weight of 1419.5 g/mol:

• Gross solid mass: 10.0 mg
• Actual peptide mass: 10.0 × 0.82 = 8.2 mg
• Target compound within that: 8.2 × 0.993 = 8.14 mg
• Reconstituted in 2 mL, true concentration: 4.07 mg/mL, not 5.0 mg/mL
• Molarity: 8.14 mg ÷ 1419.5 g/mol ÷ 2 mL = 2.87 mM, not the 3.52 mM you would calculate from gross mass

An 18% error, introduced before the first dilution, propagating through every subsequent step. For a binding assay or a dose-response curve, that is the difference between a usable result and a misleading one.

Why 99% rather than higher

Solid-phase synthesis is stepwise. Each coupling has an efficiency below 100%, and the failures accumulate: even at 99.5% per-step efficiency, a 15-residue peptide caps out around 93% purity before purification. Preparative HPLC then removes the deletion and truncation products.

Purification is a trade-off against yield. Pushing from 99% to 99.9% means discarding an increasing fraction of usable material at the peak shoulders. Beyond a point the cost is disproportionate to any analytical benefit.

This is why a catalog claiming 99.9% across every sequence invites scepticism. Real synthesis produces real variance — a 4-residue peptide and a 44-residue peptide do not purify to the same level with the same effort, and a specification that ignores that distinction is a specification nobody is measuring against.

What to require

A complete purity picture requires four numbers, not one:

With all four you can calculate a true concentration. With only the first you are estimating, and the estimate is systematically high.

Practical guidance

Where your work depends on molar accuracy — receptor binding, enzyme kinetics, dose-response — calculate from net peptide content and verify the identity confirmation. Where relative comparison within a single lot is sufficient, gross mass is workable provided every arm of the experiment uses the same lot. It is the comparison across lots, using gross mass, that quietly produces irreproducible results.